Sample information curated by ChIP-Atlas

Antigen

Antigen Class
Unclassified
Antigen
Unclassified

Cell type

Cell type Class
Breast
Cell type
LY2
NA
NA

Attributes by original data submitter

Sample

source_name
LY2 Breast Cancer Cell Line
treatment
Untreated
cell line
LY2

Sequenced DNA Library

library_strategy
ChIP-Seq
library_source
GENOMIC
library_selection
ChIP
library_construction_protocol
Cells were treated and harvested for ChIP-seq as described previously (Schmidt et al, 2009, http://www.ncbi.nlm.nih.gov/pubmed/19275939). The anti-ER (sc-543) from Santa Cruz Biotechnologies was used as the antibody. Chromatin was extracted from the cells and the protein of interest, along with the DNA attached, was immunoprecipitated using the antibody attached to Dynal beads (Dynabeads® Protein A 10001D, Life Technologies). The proteins were then removed from the DNA by reverse crosslinking overnight and the DNA purified and amplified before being sequenced. DNA libraries were generated from ChIP output DNA by adaptor ligation, gel purification, and cycles of PCR as described by Illumina.

Sequencing Platform

instrument_model
Illumina Genome Analyzer II

hg38

Number of total reads
29911659
Reads aligned (%)
83.3
Duplicates removed (%)
16.4
Number of peaks
344 (qval < 1E-05)

hg19

Number of total reads
29911659
Reads aligned (%)
82.7
Duplicates removed (%)
17.9
Number of peaks
861 (qval < 1E-05)

Base call quality data from DBCLS SRA